Vaginal composition comprising a combination of estrogen and vitamin D
US11590145B2 · kind B2 · utility
0Cited by
8References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2020 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Nov 19, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 1 μg to 100 μg estrogen of estradiol equivalent and (ii) vitamin D or analog ranging from 7.5 μg to 100 μg of vitamin D equivalent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.